The Bio Report cover image

The Year in Biotech and What’s Ahead in 2023

The Bio Report

00:00

Alzheimer's Drugs in 2023?

The biggest thing will be Lecadam app and just the rollout in 2023. Biogen was among the companies to name a new CEO, Chris Vibacher,. The one time stenophie CEO is scheduled to speak at JP Morgan conference soon.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app